Interlamellar cohesion after corneal crosslinking using riboflavin and ultraviolet A light

Br J Ophthalmol. 2011 Jun;95(6):876-80. doi: 10.1136/bjo.2010.190843. Epub 2011 Feb 25.

Abstract

Aims: Collagen crosslinking treatment of progressive keratoconus using the photosensitiser riboflavin and ultraviolet A light of 370 nm wavelength has been shown to increase significantly the tensile strength of corneal collagen by about 300%. In keratoconus, interlamellar and interfibrillar slippage have been proposed as pathogenetic mechanisms. Therefore, the aim of this study was to assess the impact of collagen crosslinking on the interlamellar cohesive force.

Methods: 72 post mortem porcine eyes were divided into six different treatment groups: the untreated control group, the standard crosslinking group, the hypo-osmolar crosslinking group, the stromal swelling group, the formaldehyde group and the α-amylase group. An anterior 9×4 mm strip of 400 μm thickness was prepared using a lamellar rotating microkeratome. For interlamellar cohesive force measurements a splitting plane was created at 50% depth. Force-distance profiles were recorded using a microcomputer-controlled biomaterial testing machine.

Results: The mean interlamellar cohesive force was 0.24 N/mm in the untreated control group, 0.26 N/mm in the standard crosslinking group, 0.25 N/mm in the hypo-osmolar crosslinking group, 0.23 N/mm in hydrated corneas, 0.27 N/mm in the formaldehyde group without statistically significant difference. Only the values of the α-amylase group were statistically significantly lowered by 31.5% to 0.16 N/mm.

Conclusions: Surprisingly, corneal crosslinking does not increase the interlamellar cohesive force. In the α-amylase group the cohesive force was mainly decreased because of the digestion of proteoglycans. Crosslinking seems to stabilise only inter- and intrafibrillar, but not interlamellar cohesion.

MeSH terms

  • Animals
  • Collagen / drug effects*
  • Cross-Linking Reagents / administration & dosage
  • Endothelium, Corneal / drug effects*
  • Endothelium, Corneal / pathology
  • Keratoconus / drug therapy*
  • Keratoconus / pathology
  • Photosensitizing Agents / administration & dosage*
  • Riboflavin / administration & dosage*
  • Swine
  • Tensile Strength / drug effects*
  • Tensile Strength / physiology
  • Ultraviolet Rays

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin